Cellromax Science Co., Ltd. (KOSDAQ:471820)
5,320.00
 -30.00 (-0.56%)
  At close: Oct 21, 2025
-0.56% (1Y)
| Market Cap | 58.29B | 
| Revenue | n/a | 
| Net Income | n/a | 
| Shares Out | 11.32M | 
| EPS | n/a | 
| PE Ratio | n/a | 
| Forward PE | n/a | 
| Dividend | 35.00 (0.68%) | 
| Ex-Dividend Date | Sep 29, 2025 | 
| Volume | 24,758 | 
| Average Volume | 41,275 | 
| Open | 5,310.00 | 
| Previous Close | 5,350.00 | 
| Day's Range | 5,300.00 - 5,480.00 | 
| 52-Week Range | 4,355.00 - 8,840.00 | 
| Beta | n/a | 
| RSI | 38.18 | 
| Earnings Date | Nov 27, 2025 |